Xos, Inc. Secures Purchase Order from Mission Linen Supply for New 22’ Stepvan Option
LOS ANGELES, Feb. 29, 2024 (GLOBE NEWSWIRE) — Xos, Inc. (NASDAQ: XOS), a leading provider of medium-duty electric vehicles, charging […]
Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results
– Reports YCANTH™ revenue of $1.9M for fourth quarter and $4.7M for full year 2023 – – Over 200 million lives […]
Evaxion to Host R&D Day on March 19, 2024, Highlighting its Latest Technology Innovations
COPENHAGEN, Denmark, Feb. 29, 2024 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio […]
Bitcoin Well Launches Customer Loyalty Program Alongside the Bitcoin Jackpot Contest and Partnership With Simply Bitcoin
EDMONTON, Alberta, Feb. 29, 2024 (GLOBE NEWSWIRE) — Bitcoin Well Inc. (“Bitcoin Well” or the “Company”) (TSXV: BTCW; OTCQB: BCNWF), […]
MariMed Introduces New and Improved Vibations™ Cannabis and Electrolyte Drink Mix
NORWOOD, Mass., Feb. 29, 2024 (GLOBE NEWSWIRE) — Vibations, the cannabis and electrolyte drink mix that delivers advanced hydration, has […]
TSX News -
Knight Therapeutics Announces Launch of Minjuvi® in Brazil
MONTREAL, Feb. 29, 2024 (GLOBE NEWSWIRE) — Knight Therapeutics Inc., (TSX: GUD) (“Knight”), a pan-American (ex-USA) specialty pharmaceutical company, announced […]
TSX News -
Avicanna Hosts Symposium on Cannabinoid-based Medicine
TORONTO, Feb. 29, 2024 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a […]
TSX News -
GURU Organic Energy to Report First Quarter 2024 Results and to Host Virtual Annual Meeting
MONTREAL, Feb. 29, 2024 (GLOBE NEWSWIRE) — GURU Organic Energy Corp. (TSX: GURU) (“GURU” or the “Company”), Canada’s leading organic […]
Churchill Confirms District-Scale Magmatic Intrusive Trend at Taylor Brook Nickel Project, Newfoundland & Labrador
TORONTO, Feb. 29, 2024 (GLOBE NEWSWIRE) — Churchill Resources Inc. (“Churchill” or the “Company”) (TSXV: CRI) is pleased to announce […]
Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024
ALPHARETTA, Ga., Feb. 29, 2024 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies […]
